STOCK TITAN

Agilysys Financials

AGYS
Source SEC Filings (10-K/10-Q) Updated May 21, 2026 Currency USD FYE May

This page shows Agilysys (AGYS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AGYS FY2025

Agilysys is turning high gross margins into reliable cash flow while a much larger FY2025 balance sheet points to purchased growth.

FY2025's balance-sheet expansion did not come from building more physical capacity: goodwill rose to $130.6M from $32.8M. With capex only $2.8M and free cash flow still positive, the company appears to be enlarging itself through purchased assets rather than a heavier internal buildout, which also helps explain why assets and liabilities grew faster than the revenue base.

Reported earnings need context: FY2024 net margin reached 36.3% while operating margin was just 6.6%, so that year's profit surge was driven well below the operating line rather than by a sudden jump in core unit economics. That makes FY2025's lower net income easier to read as normalization of taxes and other non-operating items, not a reset in the core sales engine.

Cash generation is sturdier than accounting profit alone suggests because free cash flow margin improved to 19.0% from 16.8% across FY2022-FY2025, indicating the model converts growth into cash without requiring much ongoing reinvestment. At the same time, liquidity tightened as cash fell to $73.0M and the current ratio narrowed to 1.1x, so that cash productivity now sits on a thinner short-term cushion after the FY2025 expansion.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 62 / 100
Financial Profile 62/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Agilysys's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
100

Agilysys has an operating margin of 104.5%, meaning the company retains $104 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 8.2% the prior year.

Growth
0

Agilysys's revenue declined 85.1% year-over-year, from $275.6M to $41.2M. This contraction results in a growth score of 0/100.

Leverage
100

Agilysys carries a low D/E ratio of 0.07, meaning only $0.07 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
25

Agilysys's current ratio of 1.47 is below the typical benchmark, resulting in a score of 25/100. However, the company holds substantial cash reserves (93% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.

Cash Flow
100

Agilysys converts 165.5% of revenue into free cash flow ($68.1M). This strong cash generation earns a score of 100/100.

Returns
46

Agilysys's ROE of 11.9% shows moderate profitability relative to equity, earning a score of 46/100. This is up from 8.7% the prior year.

Altman Z-Score Safe
8.76

Agilysys scores 8.76, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.0B) relative to total liabilities ($154.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral
6/9

Agilysys passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.80x

For every $1 of reported earnings, Agilysys generates $1.80 in operating cash flow ($70.0M OCF vs $38.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
87.3x

Agilysys earns $87.3 in operating income for every $1 of interest expense ($43.0M vs $493K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$41.2M
YoY-85.1%
5Y CAGR-21.4%
10Y CAGR-10.2%

Agilysys generated $41.2M in revenue in fiscal year 2026. This represents a decrease of 85.1% from the prior year.

EBITDA
$52.6M
YoY+74.6%

Agilysys's EBITDA was $52.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 74.6% from the prior year.

Net Income
$38.8M
YoY+67.0%

Agilysys reported $38.8M in net income in fiscal year 2026. This represents an increase of 67.0% from the prior year.

EPS (Diluted)
$1.37
YoY+67.1%

Agilysys earned $1.37 per diluted share (EPS) in fiscal year 2026. This represents an increase of 67.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$68.1M
YoY+30.2%
5Y CAGR+20.3%
10Y CAGR+48.4%

Agilysys generated $68.1M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 30.2% from the prior year.

Cash & Debt
$116.9M
YoY+60.0%
5Y CAGR+3.3%
10Y CAGR+6.8%

Agilysys held $116.9M in cash against $24.0M in long-term debt as of fiscal year 2026.

Dividends Per Share
N/A
Shares Outstanding
28M
YoY+0.5%
5Y CAGR+3.3%
10Y CAGR+2.1%

Agilysys had 28M shares outstanding in fiscal year 2026. This represents an increase of 0.5% from the prior year.

Margins & Returns

Gross Margin
40.8%
YoY-21.6pp
5Y CAGR-24.3pp
10Y CAGR-15.7pp

Agilysys's gross margin was 40.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 21.6 percentage points from the prior year.

Operating Margin
104.5%
YoY+96.3pp
5Y CAGR+119.8pp
10Y CAGR+108.1pp

Agilysys's operating margin was 104.5% in fiscal year 2026, reflecting core business profitability. This is up 96.3 percentage points from the prior year.

Net Margin
94.2%
YoY+85.8pp
5Y CAGR+109.5pp
10Y CAGR+97.4pp

Agilysys's net profit margin was 94.2% in fiscal year 2026, showing the share of revenue converted to profit. This is up 85.8 percentage points from the prior year.

Return on Equity
11.9%
YoY+3.1pp
5Y CAGR+38.2pp
10Y CAGR+14.9pp

Agilysys's ROE was 11.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 3.1 percentage points from the prior year.

Capital Allocation

R&D Spending
$72.7M
YoY+16.6%
5Y CAGR+5.6%
10Y CAGR+10.5%

Agilysys invested $72.7M in research and development in fiscal year 2026. This represents an increase of 16.6% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$1.8M
YoY-33.6%
5Y CAGR+5.9%
10Y CAGR-11.0%

Agilysys invested $1.8M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 33.6% from the prior year.

AGYS Income Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Revenue $80.4M+1.4% $79.3M+3.4% $76.7M+3.2% $74.3M+6.8% $69.6M+1.9% $68.3M+7.5% $63.5M+2.1% $62.2M
Cost of Revenue $30.1M-0.6% $30.3M+3.2% $29.4M+0.5% $29.2M+13.7% $25.7M+2.6% $25.1M+6.0% $23.6M-1.3% $23.9M
Gross Profit $50.2M+2.6% $49.0M+3.5% $47.3M+5.0% $45.1M+2.7% $43.9M+1.5% $43.2M+8.4% $39.9M+4.2% $38.3M
R&D Expenses $18.9M+6.2% $17.8M+2.1% $17.5M+5.5% $16.5M+10.5% $15.0M-7.4% $16.2M+9.9% $14.7M+3.1% $14.3M
SG&A Expenses $10.8M+6.6% $10.2M-5.5% $10.8M+115.6% -$68.8M-288.8% $36.4M-6.8% $39.1M+14.6% $34.1M-1.9% $34.8M
Operating Income $11.7M-17.1% $14.1M+212.9% $4.5M-14.8% $5.3M-28.4% $7.4M+79.6% $4.1M-28.2% $5.7M+65.0% $3.5M
Interest Expense $30K-46.4% $56K-74.2% $217K-47.6% $414K-37.0% $657K+43.4% $458K $0 $0
Income Tax $3.0M-25.4% $4.0M+9858.5% -$41K-102.8% $1.4M-63.0% $3.9M+3.5% $3.8M+156.2% -$6.7M-457.2% $1.9M
Net Income $9.9M-15.5% $11.7M+139.5% $4.9M+24.6% $3.9M+2.5% $3.8M+180.8% $1.4M-90.3% $14.1M+376.4% $3.0M
EPS (Diluted) $0.35-14.6% $0.41+141.2% $0.17 N/A $0.14+180.0% $0.05-90.0% $0.50 N/A

AGYS Balance Sheet

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Total Assets $475.2M+11.7% $425.6M-0.1% $426.0M-1.9% $434.4M-2.1% $443.9M+0.4% $442.0M+24.3% $355.7M+1.5% $350.4M
Current Assets $169.8M+43.9% $118.0M+8.7% $108.5M-12.1% $123.5M-5.9% $131.2M+20.7% $108.7M-41.8% $186.8M-1.1% $188.9M
Cash & Equivalents $81.5M+37.3% $59.3M+6.8% $55.6M-23.9% $73.0M+20.2% $60.8M+10.7% $54.9M-61.9% $144.1M-0.5% $144.9M
Inventory $7.8M+1.0% $7.7M+16.5% $6.6M+28.0% $5.2M-18.6% $6.4M-1.3% $6.4M+21.6% $5.3M+15.5% $4.6M
Accounts Receivable $63.7M+73.1% $36.8M+5.0% $35.1M+11.2% $31.5M-36.0% $49.3M+55.9% $31.6M+15.8% $27.3M-7.2% $29.4M
Goodwill $135.8M+1.3% $134.1M-1.4% $136.1M+4.2% $130.6M+1.6% $128.5M-5.1% $135.4M+314.7% $32.7M-0.4% $32.8M
Total Liabilities $162.1M+25.8% $128.8M-9.8% $142.8M-15.2% $168.5M-9.9% $187.1M+2.9% $181.7M+79.0% $101.5M-10.9% $114.0M
Current Liabilities $129.9M+34.3% $96.7M-0.8% $97.6M-12.1% $111.0M-3.4% $115.0M+19.9% $95.9M+23.9% $77.4M-13.4% $89.4M
Long-Term Debt $0 $0-100.0% $12.0M-50.0% $24.0M-36.8% $38.0M-24.0% $50.0M N/A $0
Total Equity $313.1M+5.5% $296.7M+4.8% $283.2M+6.5% $265.9M+3.5% $256.8M-1.3% $260.3M+2.4% $254.2M+7.5% $236.5M
Retained Earnings $187.5M+5.6% $177.6M+7.1% $165.9M+3.0% $161.0M+2.5% $157.1M+2.5% $153.2M+0.9% $151.9M+10.2% $137.8M

AGYS Cash Flow Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Operating Cash Flow $23.3M+53.1% $15.2M+450.0% -$4.3M-116.0% $27.2M+33.8% $20.3M+207.9% $6.6M+500.2% $1.1M-96.3% $29.8M
Capital Expenditures $574K+164.5% $217K-65.7% $633K-9.7% $701K+24.7% $562K-13.7% $651K-25.1% $869K+85.3% $469K
Free Cash Flow $22.7M+51.5% $15.0M+401.2% -$5.0M-118.8% $26.5M+34.1% $19.7M+232.1% $5.9M+2493.4% $229K-99.2% $29.3M
Investing Cash Flow -$574K-164.5% -$217K+65.7% -$633K+58.1% -$1.5M-156.7% -$589K+99.6% -$145.6M-16654.4% -$869K-1598.3% $58K
Financing Cash Flow -$615K+94.4% -$11.0M+14.6% -$12.9M+3.0% -$13.3M+0.8% -$13.4M-127.1% $49.6M+5462.7% -$925K+20.2% -$1.2M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

AGYS Financial Ratios

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Gross Margin 62.5%+0.7pp 61.8%+0.1pp 61.7%+1.0pp 60.7%-2.4pp 63.0%-0.2pp 63.3%+0.5pp 62.8%+1.3pp 61.5%
Operating Margin 14.6%-3.3pp 17.8%+11.9pp 5.9%-1.2pp 7.1%-3.5pp 10.7%+4.6pp 6.0%-3.0pp 9.0%+3.4pp 5.6%
Net Margin 12.3%-2.5pp 14.8%+8.4pp 6.4%+1.1pp 5.3%-0.2pp 5.5%+3.5pp 2.0%-20.2pp 22.2%+17.4pp 4.8%
Return on Equity 3.2%-0.8pp 4.0%+2.2pp 1.7%+0.2pp 1.5%0.0pp 1.5%+1.0pp 0.5%-5.0pp 5.5%+4.3pp 1.3%
Return on Assets 2.1%-0.7pp 2.8%+1.6pp 1.1%+0.3pp 0.9%+0.0pp 0.9%+0.5pp 0.3%-3.7pp 4.0%+3.1pp 0.8%
Current Ratio 1.31+0.1 1.22+0.1 1.110.0 1.11-0.0 1.140.0 1.13-1.3 2.41+0.3 2.11
Debt-to-Equity 0.000.0 0.00-0.0 0.04-0.0 0.09-0.1 0.15-0.0 0.19-0.2 0.40+0.4 0.00
FCF Margin 28.3%+9.4pp 18.9%+25.4pp -6.5%-42.1pp 35.6%+7.3pp 28.4%+19.7pp 8.7%+8.3pp 0.4%-46.8pp 47.1%

Similar Companies

Frequently Asked Questions

Agilysys (AGYS) reported $41.2M in total revenue for fiscal year 2026. This represents a -85.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Agilysys (AGYS) revenue declined by 85.1% year-over-year, from $275.6M to $41.2M in fiscal year 2026.

Yes, Agilysys (AGYS) reported a net income of $38.8M in fiscal year 2026, with a net profit margin of 94.2%.

Agilysys (AGYS) reported diluted earnings per share of $1.37 for fiscal year 2026. This represents a 67.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Agilysys (AGYS) had EBITDA of $52.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, Agilysys (AGYS) had $116.9M in cash and equivalents against $24.0M in long-term debt.

Agilysys (AGYS) had a gross margin of 40.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Agilysys (AGYS) had an operating margin of 104.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Agilysys (AGYS) had a net profit margin of 94.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Agilysys (AGYS) has a return on equity of 11.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Agilysys (AGYS) generated $68.1M in free cash flow during fiscal year 2026. This represents a 30.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Agilysys (AGYS) generated $70.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Agilysys (AGYS) had $481.5M in total assets as of fiscal year 2026, including both current and long-term assets.

Agilysys (AGYS) invested $1.8M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Agilysys (AGYS) invested $72.7M in research and development during fiscal year 2026.

Agilysys (AGYS) had 28M shares outstanding as of fiscal year 2026.

Agilysys (AGYS) had a current ratio of 1.47 as of fiscal year 2026, which is considered adequate.

Agilysys (AGYS) had a debt-to-equity ratio of 0.07 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Agilysys (AGYS) had a return on assets of 8.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Agilysys (AGYS) has an Altman Z-Score of 8.76, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Agilysys (AGYS) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Agilysys (AGYS) has an earnings quality ratio of 1.80x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Agilysys (AGYS) has an interest coverage ratio of 87.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Agilysys (AGYS) scores 62 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top